000			02230 a2200577 4500
005			20250513091509.0
264		0	_c19960731
008			199607s 0 0 eng d
022			_a0006-4971
040			_aNLM _beng _cNLM
100	1		_aSoslow, R A
245	0	0	_aTrue histiocytic lymphoma following therapy for lymphoblastic neoplasms. _h[electronic resource]
260			_bBlood _cJun 1996
300			_a5207-12 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aAsparaginase _xadministration & dosage
650	0	4	_aBone Neoplasms _xchemically induced
650	0	4	_aChild
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDaunorubicin _xadministration & dosage
650	0	4	_aEtoposide _xadministration & dosage
650	0	4	_aFatal Outcome
650	0	4	_aHumans
650	0	4	_aIfosfamide _xadministration & dosage
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xchemically induced
650	0	4	_aMale
650	0	4	_aMediastinal Neoplasms _xdrug therapy
650	0	4	_aMercaptopurine _xadministration & dosage
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMethylprednisolone _xadministration & dosage
650	0	4	_aNeoplasms, Second Primary _xchemically induced
650	0	4	_aNeoplastic Stem Cells _xpathology
650	0	4	_aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aPrednisolone _xadministration & dosage
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aRemission Induction
650	0	4	_aScapula _xpathology
650	0	4	_aSpinal Neoplasms _xchemically induced
650	0	4	_aVincristine _xadministration & dosage
700	1		_aDavis, R E
700	1		_aWarnke, R A
700	1		_aCleary, M L
700	1		_aKamel, O W
773	0		_tBlood _gvol. 87 _gno. 12 _gp. 5207-12
999			_c8651872 _d8651872